Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s traded shares stood at 1.87 million during the last session, with the company’s beta value hitting 1.30. At the close of trading, the stock’s price was $1.14, to imply an increase of 15.04% or $0.15 in intraday trading. The ADIL share’s 52-week high remains $4.17, putting it -265.79% down since that peak but still an impressive 33.33% since price per share fell to its 52-week low of $0.76. The company has a valuation of $7.30M, with an average of 86240.0 shares in intraday trading volume over the past 10 days and average of 120.95K shares over the past 3 months.
Adial Pharmaceuticals Inc (NASDAQ:ADIL) trade information
After registering a 15.04% upside in the last session, Adial Pharmaceuticals Inc (ADIL) has traded red over the past five days. The 5-day price performance for the stock is 6.54%, and 10.68% over 30 days. With these gigs, the year-to-date price performance is -38.71%. Short interest in Adial Pharmaceuticals Inc (NASDAQ:ADIL) saw shorts transact 78882.0 shares and set a 0.65 days time to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Adial Pharmaceuticals Inc (ADIL) estimates and forecasts
Looking at statistics comparing Adial Pharmaceuticals Inc share performance against respective industry, we note that the company has outperformed competitors. Adial Pharmaceuticals Inc (ADIL) shares are -19.15% down over the last 6 months, with its year-to-date growth rate higher than industry average at 32.79% against 16.90%. Revenue is forecast to shrink -8.11% this quarter before jumping 41.28% for the next one.
ADIL Dividends
Adial Pharmaceuticals Inc has its next earnings report out in December. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s Major holders
Adial Pharmaceuticals Inc insiders hold 1.80% of total outstanding shares, with institutional holders owning 3.74% of the shares at 3.81% float percentage. In total, 3.74% institutions holds shares in the company.
